Fujifilm Hldgs Corp (FUJIY) 30.9700 $FUJIY
Cempra, Inc. Receives $10 Million Milestone Payment From Toyama Chemical Co. Triggered by Solithromycin's Clinical Development Progress in Japan
GlobeNewswire - Tue Sep 09, 7:00AM CDT
Cempra, Inc. (Nasdaq:CEMP) today announced the receipt of a $10 million milestone payment from Toyama Chemical Co., a subsidiary of FUJIFILM Holdings Corporation, triggered by Toyama's progress of its solithromycin clinical development program in Japan, the world's second largest antibiotic market. The payment was made following Toyama's receipt of regulatory clearance to begin a Phase 2 trial of solithromycin in Japan following successful completion of a Phase 1 study.
Looking for Value? Why It Might Be Time to Try FUJIFILM Holdings (FUJIY) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 7:48AM CDT
FUJIFILM Holdings may be an interesting play thanks to its forward PE of 16.06, its P/S ratio of 0.61, and its decent dividend yield of 1.2%.
Laparoscopy Devices Market - Global Industry Analysis to 2019
M2 - Mon Sep 01, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mvzpjh/laparoscopy) has announced the addition of the "Laparoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global laparoscopy devices market was valued at USD 7.5 billion in 2012 and is expected to grow at a CAGR of 7.1% from 2013 to 2019, to reach an estimated value of USD 12.3 billion by 2019. The global laparoscopy devices market comprises of equipment such as laparoscope, irrigation system, insufflation devices, trocars, sample retrieval bag, wound protector, internal closure devices, gastric band, hand-assist devices, and energy systems. The segments accounting for large shares in the market include energy systems, trocars, internal closure devices and laparoscope. Although the global market is exhibiting healthy growth rate of 7.1% CAGR over the forecast period, its growth is restrained by certain side effects of laparoscopic procedures, risk of carbon dioxide emissions, and rapidly changing technologies. Introduction of newer technologies will create need for adaptive endoscope accessories. The introduction of innovative techniques such as HD systems in diagnostic instruments, HD cameras and HDTV three chip systems the demand for advanced endoscopy devices have been triggered and this scenario will continue in future. On the basis of applications, the global market for laparoscopy devices is segmented into five major segments, namely, general surgery, bariatric surgery, colorectal surgeries, urological and gynecological surgeries. General surgery accounts for the largest share in the market but the bariatric surgery is the fastest growing application segment immediately followed by colorectal surgery application. The increasing adoption of laparoscopic surgeries for colorectal cancer treatment is due to smaller incisions compared to open colectomy which results into faster recovery and less pain after surgery. Report Scope Laparoscopy Devices Market - Laparoscopes - Irrigation Systems - Insufflation Devices - Trocars - Sample Retrieval Bags - Wound Protectors - Internal Closure Devices - Gastric Bands - Hand-Assist Devices - Energy Systems Company Profiles - Braun Melsungen AG - Boston Scientific Corporation - Cook Medical, Inc. - Covidien PLC - FUJIFILM Holdings Corporation - KARL STORZ GmbH & Co. KG - Olympus Corporation - Richard Wolf GmbH - Smith & Nephew PLC - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/mv...aparoscopy
Japan ready to offer flu drug for Ebola treatment
By MARI YAMAGUCHI - AP - Mon Aug 25, 12:44PM CDT
TOKYO (AP) — Japan said Monday it is ready to provide a Japanese-developed anti-influenza drug as a possible treatment for the rapidly expanding Ebola outbreak.
How Will Fujifilm (FUJIY) Stock Be Boosted By Ebola Drug Approval?
at The Street - Thu Aug 07, 11:54AM CDT
U.S. government researchers are working to get an experimental flu drug from the Japan-based company quickly approved to treat Ebola.
Fujifilm's Q1 Earnings Rise; Revenues Drop Year over Year - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:35AM CDT
Fujifilm (FUJIY) reports mixed results for fiscal first-quarter 2015, with year over year improvement in net income while revenues declined.
TriQuint Beats on Q2 Earnings; Bullish Outlook for 2H14 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 2:20PM CDT
TriQuint (TQNT) reported adjusted earnings of 13 cents per share, beating the Zacks Consensus Estimate of 3 cents. The company benefited from its portfolio restructuring efforts toward higher-value solutions.
Why FUJIFILM Holdings (FUJIY) is Such a Great Value Stock Pick Right Now - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 14, 7:37AM CDT
FUJIFILM Holdings (FUJIY) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and of late, it is seeing solid earnings estimate revisions as well.
Fujifilm Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 9:30AM CDT
Zacks Investment Research upgraded Fujifilm Holdings (FUJIY) to a Zacks Rank #1 (Strong Buy) on Jul 9, based on its efforts to innovate technologies.
FUJIFILM Supports Warrior Hike as New Sponsor
Business Wire - Wed Apr 02, 9:28AM CDT
FUJIFILM Holdings America Corporation is delighted to announce its sponsorship of Warrior Hike, a non-profit organization supporting combat veterans transitioning from their military service by hiking America's National Scenic Trails.
Melvin: Keep It Simple
at The Street - Fri Mar 21, 2:30PM CDT
You only need to ask these two questions when selecting a stock.
Risk-Wary Investors Deal Nippon Stocks A Harsh Blow
at Investor's Business Daily - Fri Mar 14, 4:42PM CDT
While U.S. markets lodged a disappointing week, markets overseas put in some of the worst performances in a year. The Tokyo Stock Exchange was hardest hit among those, with the Nikkei 225 tumbling 3.3% Friday -- leaving the index down 6.2% in its...
Updated Research Report on Fujifilm - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 6:15PM CST
On Feb 27, 2014, we issued an updated research report on Fujifilm Holdings Corporation.
Sanofi's CEO Admits Lackluster Drug Development Decade but Defends Its Pipeline: Sanofi (OTCQB: SNYNF), Royal Dutch Shell Plc (OTCQB: RYDAF), FUJIFILM Holdings Corp. (OTCPINK: FUJIY), Provectus Pharmaceuticals (OTC: PVCT)
ACCESSWIRE - Mon Feb 10, 10:12AM CST
The fierce competition coming from generic drug companies, the escalating costs of developing new drugs and the arduous process of getting them approved weighs heavily on Sanofi (OTCQB: SNYNF) and its competitors.
Fujifilm's Q3 Earnings Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 1:00PM CST
Fujifilm reports improved year-over-year results in the third quarter of fiscal 2014.
Federal Court Ruling Could Be Set Back for Royal Dutch Shell Stock: Royal Dutch Shell Plc (OTCQB: RYDAF), FUJIFILM Holdings Corp. (OTCPINK: FUJIY), Sanofi (OTCQB: SNYNF), Provectus Pharmaceuticals (OTC: PVCT)
ACCESSWIRE - Mon Jan 27, 2:01PM CST
Whether a recent federal court ruling will scrap Royal Dutch Shell Plc (OTCQB: RYDAF) Alaska drilling plans remains to be seen, but the uncertainty it creates could affect the oil company's share price.
Global Mammography Equipment Market 2014-2018: Market Witnessing the Growing use of 3D Mammography
M2 - Thu Jan 16, 5:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/pq3pxr/global) has announced the addition of the "Global Mammography Equipment Market 2014-2018" report to their offering. The analysts forecast the Global Mammography Equipment market to grow at a CAGR of 9.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of breast cancer. The Global Mammography Equipment Market 2014-2018 has also been witnessing the growing use of 3D mammography. However, the high cost of mammography equipment could pose a challenge to the growth of this market. Key vendors dominating this space are FUJIFILM Holdings Corp., GE Healthcare, Hologic Inc., Phillips Healthcare, and Siemens Healthcare. Other vendors mentioned in the report are Carestream Health Inc., Internazionale Medico Scientifica Srl, PerkinElmer Inc., Planmed Oy and Toshiba Medical Systems Corp. Commenting on the report, an analyst from the team said: With technological advancements, there has been an increase in the use of 3D mammography globally in recent years. The 3D mammography system is considered to be 7 percent more accurate compared to the traditional 2D mammography system. The 3D mammography system is currently available for commercial use in Latin America, Europe, and Asia. There is currently only one product available though, which is Selenia Dimensions 3D tomosynthesis offered by Hologic Inc. It was approved for sale in the US by the FDA on February 11, 2011 and has generated the maximum revenue for Hologic Inc. in the US. The introduction of new generation mammography equipment has enhanced the efficiency of breast cancer surgeries and treatments. 3D mammography removes overlapping tissue artifacts, especially in dense breasts and offers better screening sensitivity. Thus, the growing use of 3D mammography is expected to drive growth in the Global Mammography Equipment market. According to the report, the Global Mammography Equipment market is driven by several factors. One of the main drivers in this market is the increasing incidence of breast cancer among women which has led to an increase in the demand for mammography equipment for the accurate diagnosis of breast cancer. For more information visit http://www.researchandmarkets.com/research/pq3pxr/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Fujifilm Downgraded to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 16, 11:50AM CDT
On Sep 13, 2013, we downgraded our recommendation on Fujifilm Holdings Corporation to Neutral from Outperform.
Data on Cempra's Solithromycin - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 06, 3:25PM CDT
Cempra, Inc. announced that solithromycin, showed safety and tolerability in patients.
Cempra, Inc. Receives $10 Million Milestone Payment From Toyama Chemical Co. Triggered by Solithromycin's Clinical Development Progress in Japan
GlobeNewswire - Tue Sep 09, 7:00AM CDT
Cempra, Inc. (Nasdaq:CEMP) today announced the receipt of a $10 million milestone payment from Toyama Chemical Co., a subsidiary of FUJIFILM Holdings Corporation, triggered by Toyama's progress of its solithromycin clinical development program in Japan, the world's second largest antibiotic market. The payment was made following Toyama's receipt of regulatory clearance to begin a Phase 2 trial of solithromycin in Japan following successful completion of a Phase 1 study.
Looking for Value? Why It Might Be Time to Try FUJIFILM Holdings (FUJIY) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 7:48AM CDT
FUJIFILM Holdings may be an interesting play thanks to its forward PE of 16.06, its P/S ratio of 0.61, and its decent dividend yield of 1.2%.
Laparoscopy Devices Market - Global Industry Analysis to 2019
M2 - Mon Sep 01, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mvzpjh/laparoscopy) has announced the addition of the "Laparoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global laparoscopy devices market was valued at USD 7.5 billion in 2012 and is expected to grow at a CAGR of 7.1% from 2013 to 2019, to reach an estimated value of USD 12.3 billion by 2019. The global laparoscopy devices market comprises of equipment such as laparoscope, irrigation system, insufflation devices, trocars, sample retrieval bag, wound protector, internal closure devices, gastric band, hand-assist devices, and energy systems. The segments accounting for large shares in the market include energy systems, trocars, internal closure devices and laparoscope. Although the global market is exhibiting healthy growth rate of 7.1% CAGR over the forecast period, its growth is restrained by certain side effects of laparoscopic procedures, risk of carbon dioxide emissions, and rapidly changing technologies. Introduction of newer technologies will create need for adaptive endoscope accessories. The introduction of innovative techniques such as HD systems in diagnostic instruments, HD cameras and HDTV three chip systems the demand for advanced endoscopy devices have been triggered and this scenario will continue in future. On the basis of applications, the global market for laparoscopy devices is segmented into five major segments, namely, general surgery, bariatric surgery, colorectal surgeries, urological and gynecological surgeries. General surgery accounts for the largest share in the market but the bariatric surgery is the fastest growing application segment immediately followed by colorectal surgery application. The increasing adoption of laparoscopic surgeries for colorectal cancer treatment is due to smaller incisions compared to open colectomy which results into faster recovery and less pain after surgery. Report Scope Laparoscopy Devices Market - Laparoscopes - Irrigation Systems - Insufflation Devices - Trocars - Sample Retrieval Bags - Wound Protectors - Internal Closure Devices - Gastric Bands - Hand-Assist Devices - Energy Systems Company Profiles - Braun Melsungen AG - Boston Scientific Corporation - Cook Medical, Inc. - Covidien PLC - FUJIFILM Holdings Corporation - KARL STORZ GmbH & Co. KG - Olympus Corporation - Richard Wolf GmbH - Smith & Nephew PLC - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/mv...aparoscopy
Japan ready to offer flu drug for Ebola treatment
By MARI YAMAGUCHI - AP - Mon Aug 25, 12:44PM CDT
TOKYO (AP) — Japan said Monday it is ready to provide a Japanese-developed anti-influenza drug as a possible treatment for the rapidly expanding Ebola outbreak.
How Will Fujifilm (FUJIY) Stock Be Boosted By Ebola Drug Approval?
at The Street - Thu Aug 07, 11:54AM CDT
U.S. government researchers are working to get an experimental flu drug from the Japan-based company quickly approved to treat Ebola.
Fujifilm's Q1 Earnings Rise; Revenues Drop Year over Year - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:35AM CDT
Fujifilm (FUJIY) reports mixed results for fiscal first-quarter 2015, with year over year improvement in net income while revenues declined.
TriQuint Beats on Q2 Earnings; Bullish Outlook for 2H14 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 2:20PM CDT
TriQuint (TQNT) reported adjusted earnings of 13 cents per share, beating the Zacks Consensus Estimate of 3 cents. The company benefited from its portfolio restructuring efforts toward higher-value solutions.
Why FUJIFILM Holdings (FUJIY) is Such a Great Value Stock Pick Right Now - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 14, 7:37AM CDT
FUJIFILM Holdings (FUJIY) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and of late, it is seeing solid earnings estimate revisions as well.
Fujifilm Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 9:30AM CDT
Zacks Investment Research upgraded Fujifilm Holdings (FUJIY) to a Zacks Rank #1 (Strong Buy) on Jul 9, based on its efforts to innovate technologies.
FUJIFILM Supports Warrior Hike as New Sponsor
Business Wire - Wed Apr 02, 9:28AM CDT
FUJIFILM Holdings America Corporation is delighted to announce its sponsorship of Warrior Hike, a non-profit organization supporting combat veterans transitioning from their military service by hiking America's National Scenic Trails.
Melvin: Keep It Simple
at The Street - Fri Mar 21, 2:30PM CDT
You only need to ask these two questions when selecting a stock.
Risk-Wary Investors Deal Nippon Stocks A Harsh Blow
at Investor's Business Daily - Fri Mar 14, 4:42PM CDT
While U.S. markets lodged a disappointing week, markets overseas put in some of the worst performances in a year. The Tokyo Stock Exchange was hardest hit among those, with the Nikkei 225 tumbling 3.3% Friday -- leaving the index down 6.2% in its...
Updated Research Report on Fujifilm - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 6:15PM CST
On Feb 27, 2014, we issued an updated research report on Fujifilm Holdings Corporation.
Sanofi's CEO Admits Lackluster Drug Development Decade but Defends Its Pipeline: Sanofi (OTCQB: SNYNF), Royal Dutch Shell Plc (OTCQB: RYDAF), FUJIFILM Holdings Corp. (OTCPINK: FUJIY), Provectus Pharmaceuticals (OTC: PVCT)
ACCESSWIRE - Mon Feb 10, 10:12AM CST
The fierce competition coming from generic drug companies, the escalating costs of developing new drugs and the arduous process of getting them approved weighs heavily on Sanofi (OTCQB: SNYNF) and its competitors.
Fujifilm's Q3 Earnings Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 1:00PM CST
Fujifilm reports improved year-over-year results in the third quarter of fiscal 2014.
Federal Court Ruling Could Be Set Back for Royal Dutch Shell Stock: Royal Dutch Shell Plc (OTCQB: RYDAF), FUJIFILM Holdings Corp. (OTCPINK: FUJIY), Sanofi (OTCQB: SNYNF), Provectus Pharmaceuticals (OTC: PVCT)
ACCESSWIRE - Mon Jan 27, 2:01PM CST
Whether a recent federal court ruling will scrap Royal Dutch Shell Plc (OTCQB: RYDAF) Alaska drilling plans remains to be seen, but the uncertainty it creates could affect the oil company's share price.
Global Mammography Equipment Market 2014-2018: Market Witnessing the Growing use of 3D Mammography
M2 - Thu Jan 16, 5:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/pq3pxr/global) has announced the addition of the "Global Mammography Equipment Market 2014-2018" report to their offering. The analysts forecast the Global Mammography Equipment market to grow at a CAGR of 9.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of breast cancer. The Global Mammography Equipment Market 2014-2018 has also been witnessing the growing use of 3D mammography. However, the high cost of mammography equipment could pose a challenge to the growth of this market. Key vendors dominating this space are FUJIFILM Holdings Corp., GE Healthcare, Hologic Inc., Phillips Healthcare, and Siemens Healthcare. Other vendors mentioned in the report are Carestream Health Inc., Internazionale Medico Scientifica Srl, PerkinElmer Inc., Planmed Oy and Toshiba Medical Systems Corp. Commenting on the report, an analyst from the team said: With technological advancements, there has been an increase in the use of 3D mammography globally in recent years. The 3D mammography system is considered to be 7 percent more accurate compared to the traditional 2D mammography system. The 3D mammography system is currently available for commercial use in Latin America, Europe, and Asia. There is currently only one product available though, which is Selenia Dimensions 3D tomosynthesis offered by Hologic Inc. It was approved for sale in the US by the FDA on February 11, 2011 and has generated the maximum revenue for Hologic Inc. in the US. The introduction of new generation mammography equipment has enhanced the efficiency of breast cancer surgeries and treatments. 3D mammography removes overlapping tissue artifacts, especially in dense breasts and offers better screening sensitivity. Thus, the growing use of 3D mammography is expected to drive growth in the Global Mammography Equipment market. According to the report, the Global Mammography Equipment market is driven by several factors. One of the main drivers in this market is the increasing incidence of breast cancer among women which has led to an increase in the demand for mammography equipment for the accurate diagnosis of breast cancer. For more information visit http://www.researchandmarkets.com/research/pq3pxr/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Fujifilm Downgraded to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 16, 11:50AM CDT
On Sep 13, 2013, we downgraded our recommendation on Fujifilm Holdings Corporation to Neutral from Outperform.
Data on Cempra's Solithromycin - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 06, 3:25PM CDT
Cempra, Inc. announced that solithromycin, showed safety and tolerability in patients.
